Matthew Macaluso

This study sought to ascertain the extent that pharmacogenetic testing can inform treatment decisions among patients with treatment-resistant depression whose medications are subject to gene-drug interactions—read the article to...

Weight gain is a major problem with second-generation antipsychotics. Here, delve into the case of a patient diagnosed with schizophrenia, catatonic type, who gained 84 lb during 14 months...

Permanent brain damage, long-term institutionalization, and death can result from undiagnosed and untreated Wernicke's encephalopathy. Too many cases are not diagnosed until autopsy. Do you know which patients are...

Yellow Ribbon is a gatekeeper-type suicide prevention program that is widely used in public schools. However, data on its effectiveness are limited. Thus, the authors of this Continuing Medical...

How do you avoid drug-drug interactions in your patients who are taking multiple medications? This article explains the process for assessing the risk of a drug causing or being...

 

Prior meta-analyses have found vortioxetine to be efficacious for depression. Building on those findings, the present meta-analysis examined the effect that placebo response has on drug-placebo effect size in...

Only some patients with treatment-resistant depression who ultimately respond to esketamine plus an oral antidepressant do so within the first 2 doses. This study estimated the likelihood of ultimate...

Extension for Community Health Outcomes (ECHO) Depression was designed to improve health care delivery for depressed patients in Alabama, which is particularly important during the COVID-19 pandemic. Read on...